Risk stratification for clinical severity of pulmonary embolism in patients with cancer: a narrative review and MASCC clinical guidance for daily care.
Acute pulmonary embolism
Cancer-associated venous thromboembolism
Supportive care oncology
Unsuspected pulmonary embolism
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
21
10
2021
accepted:
09
05
2022
pubmed:
18
5
2022
medline:
28
9
2022
entrez:
17
5
2022
Statut:
ppublish
Résumé
Pulmonary embolism (PE) is a leading cause of morbidity and mortality in patients with cancer. The clinical presentation and outcomes of PE range from an acute life-threatening condition requiring intensive care to a mild symptomatic condition associated with favorable outcomes and potentially candidate for early hospital discharge. The wide clinical spectrum of PE has led to the development of risk stratification models aimed at the triage of patients in emergency care departments and optimizing the utilization of health care resources. Incidental or unsuspected PE (UPE), detected during routine staging computed tomography scans, make up a significant proportion of this cohort among the oncology population. The present narrative review is aimed at examining the currently available PE risk assessment models developed for the general population and for patients with cancer including UPE. We include general recommendations for the daily care of patients with cancer-related PE and hypothesize on the factors that would potentially favor hospitalization with early discharge or ambulatory management in this setting.
Identifiants
pubmed: 35579753
doi: 10.1007/s00520-022-07131-1
pii: 10.1007/s00520-022-07131-1
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
8527-8538Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Khorana AA, Francis CW, Culakova E, Kuderer NM, Lyman GH (2007) Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. J Thromb Haemost 5:632–634
pubmed: 17319909
doi: 10.1111/j.1538-7836.2007.02374.x
Sørensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343:1846–1850
pubmed: 11117976
doi: 10.1056/NEJM200012213432504
Prandoni P, Lensing AW, Piccioli A et al (2002) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood 100:3484–3488
pubmed: 12393647
doi: 10.1182/blood-2002-01-0108
Timp JF, Braekkan SK, Versteeg HH, Cannegieter SC (2013) Epidemiology of cancer-associated venous thrombosis. Blood 122:1712–1723
pubmed: 23908465
doi: 10.1182/blood-2013-04-460121
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249
pubmed: 33538338
doi: 10.3322/caac.21660
Browne AM, Cronin CG, English C, NiMhuircheartaigh J, Murphy JM, Bruzzi JF (2010) Unsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imaging. J Thorac Oncol 5:798–803
pubmed: 20421822
doi: 10.1097/JTO.0b013e3181d6153a
Tapson VF (2008) Acute pulmonary embolism. N Engl J Med 6(358):1037–1052
doi: 10.1056/NEJMra072753
Agnelli G, Becattini C (2010) Acute pulmonary embolism. N Engl J Med 363:266–274
pubmed: 20592294
doi: 10.1056/NEJMra0907731
Cooksley T, Rice T (2017) Emergency oncology: development, current position and future direction in the USA and UK. Support Care Cancer 25:3–7
pubmed: 27815712
doi: 10.1007/s00520-016-3470-1
Todd KH, Thomas CR Jr (2016) An inflection point in the evolution of oncologic emergency medicine. Ann Emerg Med 68:712–716
pubmed: 27038693
doi: 10.1016/j.annemergmed.2016.03.008
Berman R, Davies A, Cooksley T, Gralla R, Carter L, Darlington E et al (2020) Supportive care: an indispensable component of modern oncology. Clin Oncol 32:781–788
doi: 10.1016/j.clon.2020.07.020
Hui D, Bruera E (2016) Integrating palliative care into the trajectory of cancer care. Nat Rev Clin Oncol 13:159–171
pubmed: 26598947
doi: 10.1038/nrclinonc.2015.201
Martinez Licha CR, McCurdy CM, Maldonado SM, Lee LS (2020) Current management of acute pulmonary embolism. Ann Thorac Cardiovasc Surg 26:65–71
pubmed: 31588070
doi: 10.5761/atcs.ra.19-00158
Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP et al (2020) 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Heart J 41:543–603
pubmed: 31504429
doi: 10.1093/eurheartj/ehz405
Quezada CA, Bikdeli B, Barrios D, Barbero E, Chiluiza D, Muriel A et al (2019) Meta-analysis of prevalence and short-term prognosis of hemodynamically unstable patients with symptomatic acute pulmonary embolism. Am J Cardiol 123:684–689
pubmed: 30528278
doi: 10.1016/j.amjcard.2018.11.009
Mikkola KM, Patel SR, Parker JA, Grodstein F, Goldhaber SZ (1997) Attenuation over 24 hours of the efficacy of thrombolysis of pulmonary embolism among patients with cancer. Am Heart J 134:603–607
pubmed: 9351725
doi: 10.1016/S0002-8703(97)70041-3
Kurnicka K, Lichodziejewska B, Goliszek S, Dzikowska-Diduch O, Zdończyk O, Kozłowska M et al (2016) Echocardiographic pattern of acute pulmonary embolism: analysis of 511 consecutive patients. J Am Soc Echocardiogr 29:907–913
pubmed: 27427291
doi: 10.1016/j.echo.2016.05.016
Meinel FG, Nance JW Jr, Schoepf UJ, Hoffmann VS, Thierfelder KM, Costello P et al (2015) Predictive value of computed tomography in acute pulmonary embolism: systematic review and meta-analysis. Am J Med 128:747-759.e2
pubmed: 25680885
doi: 10.1016/j.amjmed.2015.01.023
Sanchez O, Trinquart L, Colombet I, Durieux P, Huisman MV, Chatellier G et al (2008) Prognostic value of right ventricular dysfunction in patients with haemodynamically stable pulmonary embolism: a systematic review. Eur Heart J 29:1569–1577
pubmed: 18495689
doi: 10.1093/eurheartj/ehn208
Coutance G, Cauderlier E, Ehtisham J, Hamon M, Hamon M (2011) The prognostic value of markers of right ventricular dysfunction in pulmonary embolism: a meta-analysis. Crit Care 15:R103
pubmed: 21443777
pmcid: 3219376
doi: 10.1186/cc10119
Wicki J, Perrier A, Perneger TV, Bounameaux H, Junod AF (2000) Predicting adverse outcome in patients with acute pulmonary embolism: a risk score. Thromb Haemost 84:548–552
pubmed: 11057848
doi: 10.1055/s-0037-1614065
Donzé J, Le Gal G, Fine MJ, Roy PM, Sanchez O, Verschuren F et al (2008) Prospective validation of the Pulmonary Embolism Severity Index. A clinical prognostic model for pulmonary embolism. Thromb Haemost 100:943–948
pubmed: 18989542
doi: 10.1160/TH08-05-0285
Jiménez D, Aujesky D, Moores L, Gómez V, Lobo JL, Uresandi F et al (2010) Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 170:1383–1389
pubmed: 20696966
doi: 10.1001/archinternmed.2010.199
Jiménez D, Yusen RD, Otero R, Uresandi F, Nauffal D, Laserna E et al (2007) Prognostic models for selecting patients with acute pulmonary embolism for initial outpatient therapy. Chest 132:24–30
pubmed: 17625081
doi: 10.1378/chest.06-2921
Bova C, Sanchez O, Prandoni P, Lankeit M, Konstantinides S, Vanni S et al (2014) Identification of intermediate-risk patients with acute symptomatic pulmonary embolism. Eur Respir J 44:694–703
pubmed: 24696111
doi: 10.1183/09031936.00006114
Fernández C, Bova C, Sanchez O, Prandoni P, Lankeit M, Konstantinides S et al (2015) Validation of a model for identification of patients at intermediate to high risk for complications associated with acute symptomatic pulmonary embolism. Chest 148:211–218
pubmed: 25633724
doi: 10.1378/chest.14-2551
Bova C, Vanni S, Prandoni P, Morello F, Dentali F, Bernardi E et al (2018) Bova Score Validation Study Investigators. A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism. Thromb Res 165:107–111
pubmed: 29631073
doi: 10.1016/j.thromres.2018.04.002
Dellas C, Tschepe M, Seeber V, Zwiener I, Kuhnert K, Schäfer K et al (2014) A novel H-FABP assay and a fast prognostic score for risk assessment of normotensive pulmonary embolism. Thromb Haemost 111:996–1003
pubmed: 24477222
doi: 10.1160/TH13-08-0663
Hobohm L, Becattini C, Konstantinides SV, Casazza F, Lankeit M (2020) Validation of a fast prognostic score for risk stratification of normotensive patients with acute pulmonary embolism. Clin Res Cardiol 109:1008–1017
pubmed: 32025793
pmcid: 7376081
doi: 10.1007/s00392-019-01593-w
Kabrhel C, Rosovsky R, Channick R, Jaff MR, Weinberg I, Sundt T et al (2016) A multidisciplinary pulmonary embolism response team: initial 30-month experience with a novel approach to delivery of care to patients with submassive and massive pulmonary embolism. Chest 150:384–393
pubmed: 27006156
doi: 10.1016/j.chest.2016.03.011
Zern EK, Young MN, Rosenfield K, Kabrhel C (2017) A pulmonary embolism response team: initial experiences and future directions. Expert Rev Cardiovasc Ther 15:481–489
pubmed: 28571513
doi: 10.1080/14779072.2017.1337509
Rivera-Lebron B, McDaniel M, Ahrar K, Alrifai A, Dudzinski DM, Fanola C, et al (2019) PERT Consortium. Diagnosis, treatment and follow up of acute pulmonary embolism: consensus practice from the PERT consortium. Clin Appl Thromb Hemost 25: 1076029619853037.
Carson JL, Kelley MA, Duff A, Weg JG, Fulkerson WJ, Palevsky HI et al (1992) The clinical course of pulmonary embolism. N Engl J Med 326:1240–1245
pubmed: 1560799
doi: 10.1056/NEJM199205073261902
Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI et al (2020) Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical Practice Guideline Update. J Clin Oncol 38:496–520
pubmed: 31381464
doi: 10.1200/JCO.19.01461
Lee AY, Peterson EA (2013) Treatment of cancer-associated thrombosis. Blood 122:2310–2317
pubmed: 23843493
doi: 10.1182/blood.V122.21.2310.2310
Kline JA, Roy PM, Than MP, Hernandez J, Courtney DM, Jones AE et al (2012) Derivation and validation of a multivariate model to predict mortality from pulmonary embolism with cancer: The POMPE-C tool. Thromb Res 129:e194–e199
pubmed: 22475313
pmcid: 3350789
doi: 10.1016/j.thromres.2012.03.015
den Exter PL, Gómez V, Jiménez D, Trujillo-Santos J, Muriel A, Huisman MV et al (2013) A clinical prognostic model for the identification of low-risk patients with acute symptomatic pulmonary embolism and active cancer. Chest 143:138–145
doi: 10.1378/chest.12-0964
Font C, Carmona-Bayonas A, Beato C, Reig Ò, Sáez A, Jiménez-Fonseca P et al (2017) Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study. Eur Respir J 49:1600282
pubmed: 28052954
doi: 10.1183/13993003.00282-2016
Posch F, Ay C (2017) Symptoms, signs, suspicion and setting: a PESI score for cancer-associated pulmonary embolism? Eur Respir J 49:1602225
pubmed: 28052963
doi: 10.1183/13993003.02225-2016
Carmona-Bayonas A, Jiménez-Fonseca P, Font C, Fenoy F, Otero R, Beato C et al (2017) Predicting serious complications in patients with cancer and pulmonary embolism using decision tree modelling: the EPIPHANY Index. Br J Cancer 116:994–1001
pubmed: 28267709
pmcid: 5396106
doi: 10.1038/bjc.2017.48
Ahn S, Cooksley T, Banala S, Buffardi L, Rice TW (2018) Validation of the EPIPHANY index for predicting risk of serious complications in cancer patients with incidental pulmonary embolism. Support Care Cancer 26:3601–3607
pubmed: 29725804
doi: 10.1007/s00520-018-4235-9
Meyer HJ, Wienke A, Surov A (2021) Incidental pulmonary embolism in oncologic patients-a systematic review and meta-analysis. Support Care Cancer 29:1293–1302
pubmed: 32621266
doi: 10.1007/s00520-020-05601-y
Font C, Farrús B, Vidal L, Caralt TM, Visa L, Mellado B et al (2011) Incidental versus symptomatic venous thrombosis in cancer: a prospective observational study of 340 consecutive patients. Ann Oncol 22:2101–2106
pubmed: 21325446
doi: 10.1093/annonc/mdq720
Di Nisio M, Ferrante N, De Tursi M, Iacobelli S, Cuccurullo F, Büller HR et al (2010) Incidental venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Thromb Haemost 104:1049–1054
pubmed: 20806119
doi: 10.1160/TH10-05-0277
van der Hulle T, den Exter PL, Planquette B, Meyer G, Soler S, Monreal M et al (2016) Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients. J Thromb Haemost 14:105–113
pubmed: 26469193
doi: 10.1111/jth.13172
Kraaijpoel N, Bleker SM, Meyer G, Mahé I, Muñoz A, Bertoletti L et al (2019) Treatment and long-term clinical outcomes of incidental pulmonary embolism in patients with cancer: an international prospective cohort study. J Clin Oncol 37:1713–1720
pubmed: 31116676
doi: 10.1200/JCO.18.01977
Peris M, López-Nuñez JJ, Maestre A, Jimenez D, Muriel A, Bikdeli B et al (2021) Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism. Eur Respir J 58:2002723
pubmed: 33303548
doi: 10.1183/13993003.02723-2020
Di Nisio M, Lee AY, Carrier M, Liebman HA, Khorana AA (2015) Subcommittee on haemostasis and malignancy. Diagnosis and treatment of incidental venous thromboembolism in cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost 13:880–883
pubmed: 25714858
doi: 10.1111/jth.12883
Farge D, Frere C, Connors JM, Ay C, Khorana AA, Munoz A et al (2019) International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. Lancet Oncol 20:e566–e581
pubmed: 31492632
doi: 10.1016/S1470-2045(19)30336-5
Lyman GH, Carrier M, Ay C, Di Nisio M, Hicks LK, Khorana AA et al (2021) American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer. Blood Adv 5:927–974
pubmed: 33570602
pmcid: 7903232
doi: 10.1182/bloodadvances.2020003442
Stevens SM, Woller SC, Baumann Kreuziger L, Bounameaux H, Doerschug K, Geersing GJ et al (2021) Antithrombotic therapy for VTE disease: second update of the CHEST Guideline and Expert Panel Report - Executive Summary. Chest S0012–3692(21):01507–01515
Caiano L, Carrier M, Marshall A, Young AM, Ageno W, Delluc A et al (2021) Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost 19:2468–2479
pubmed: 34161655
doi: 10.1111/jth.15435
Aujesky D, Roy PM, Verschuren F, Righini M, Osterwalder J, Egloff M et al (2011) Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet 378:41–48
pubmed: 21703676
doi: 10.1016/S0140-6736(11)60824-6
Otero R, Uresandi F, Jiménez D, Cabezudo MA, Oribe M, Nauffal D et al (2010) Home treatment in pulmonary embolism. Thromb Res 126:e1–e5
pubmed: 19853892
doi: 10.1016/j.thromres.2009.09.026
Peacock FW, Coleman CI, Diercks DB, Francis S, Kabrhel C, Keay C et al (2018) Emergency Department Discharge of Pulmonary Embolus Patients. Acad Emerg Med 25:995–1003
doi: 10.1111/acem.13451
Roy PM, Penaloza A, Hugli O, Klok FA, Arnoux A, Elias A et al (2021) HOME-PE Study Group. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial. Eur Heart J 42:3146–3157
pubmed: 34363386
pmcid: 8408662
doi: 10.1093/eurheartj/ehab373
Zondag W, Mos IC, Creemers-Schild D, Hoogerbrugge AD, Dekkers OM, Dolsma J et al (2011) Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost 9:1500–1507
pubmed: 21645235
doi: 10.1111/j.1538-7836.2011.04388.x
Howard LSGE, Barden S, Condliffe R, Connolly V, Davies CWH, Donaldson J, et al (2018) British Thoracic Society Guideline for the initial outpatient management of pulmonary embolism (PE). Thorax 73 (Suppl 2): ii1-ii29.
Peacock WF, Singer AJ (2019) Reducing the hospital burden associated with the treatment of pulmonary embolism. J Thromb Haemost 17:720–736
pubmed: 30851227
pmcid: 6849869
doi: 10.1111/jth.14423
Westafer LM, Shieh MS, Pekow PS, Stefan MS, Lindenauer PK (2021) Outpatient management of patients following diagnosis of acute pulmonary embolism. Acad Emerg Med 28:336–345
pubmed: 33248008
doi: 10.1111/acem.14181
Siragusa S, Arcara C, Malato A, Anastasio R, Valerio MR, Fulfaro F, et al (2005) Home therapy for deep vein thrombosis and pulmonary embolism in cancer patients. Ann Oncol 16 Suppl 4: iv136-iv139.
Ageno W, Grimwood R, Limbiati S, Dentali F, Steidl L, Wells PS (2005) Home-treatment of deep vein thrombosis in patients with cancer. Haematologica 90:220–224
pubmed: 15710575
Font C, Carmona-Bayonas A, Fernández-Martinez A, Beato C, Vargas A, Gascon P et al (2014) Outpatient management of pulmonary embolism in cancer: data on a prospective cohort of 138 consecutive patients. J Natl Compr Canc Netw 12:365–373
pubmed: 24616542
doi: 10.6004/jnccn.2014.0038